Regenerative therapies as a potential treatment of erectile dysfunction
- PMID: 37417556
- PMCID: PMC10330409
- DOI: 10.4111/icu.20230104
Regenerative therapies as a potential treatment of erectile dysfunction
Abstract
Erectile dysfunction (ED) is the most common sexual dysfunction disease in adult males. ED can be caused by many factors, such as vascular disease, neuropathy, metabolic disturbances, psychosocial causes, and side effects of medications. Although current oral phosphodiesterase type 5 inhibitors can achieve a certain effect, they cause temporary dilatation of blood vessels with no curative treatment effects. Emerging targeted technologies, such as stem cell therapy, protein therapy, and low-intensity extracorporeal shock wave therapy (Li-ESWT), are being used to achieve more natural and long-lasting effects in treating ED. However, the development and application of these therapeutic methods are still in their infancy, and their pharmacological pathways and specific mechanisms have not been fully discovered. This article reviews the preclinical basic research progress of stem cells, proteins, and Li-ESWT therapy, as well as the current status of clinical application of Li-ESWT therapy.
Keywords: Erectile dysfunction; Extracorporeal shockwave therapies; Proteins; Regenerative medicine; Stem cell.
© The Korean Urological Association.
Conflict of interest statement
The authors have nothing to disclose.
References
-
- Muneer A, Kalsi J, Nazareth I, Arya M. Erectile dysfunction. BMJ. 2014;348:g129. - PubMed
-
- Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol. 2000;163:460–463. - PubMed
-
- Goldstein I, Chambers R, Tang W, Stecher V, Hassan T. Real-world observational results from a database of 48 million men in the United States: relationship of cardiovascular disease, diabetes mellitus and depression with age and erectile dysfunction. Int J Clin Pract. 2018;72:e13078. - PubMed
-
- Schulster ML, Liang SE, Najari BB. Metabolic syndrome and sexual dysfunction. Curr Opin Urol. 2017;27:435–440. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
